GFAP and Alzheimer disease: Our results demonstrate a significant and largely overlapping increase in the levels of CHIT1, YKL-40, and GFAP in prion disease, AD, and FTLD, thus supporting the idea of a shared CSF neuroinflammatory profile in neurodegenerative dementias.